BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA upgrades Dr. Reddys Laboratories to buy
The brokerage says US generics will be the key growth driver for the company as underlying demand continues to be strong. However CLSA sees near term pressure on margins. Rouble devaluation to hurt earnings, it added.